SCHEMBL2270248

SCHEMBL2270248

CC(=O)N(Cl)c1ccc2c(c1NC(=O)c1cccc(F)c1)C(=O)c1ccccc1C2=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.43
ALDH1A1 P00352 2/20 0.41
TSHR P16473 1/20 0.41
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
KCNK3 O14649 2/20 0.41
LMNA P02545 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
MAPT P10636 2/20 0.40
POLB P06746 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
MCL1 Q07820 1/20 0.40
CTDSP1 Q9GZU7 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KCNQ3 O43525 2/20 0.39
KCNQ2 O43526 2/20 0.39
KCNE1 P15382 1/20 0.39
KCNQ1 P51787 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2271959 0.89 HSP90AA1 (0.45) ALDH1A1MEN1KMT2AKCNK3LMNA
SCHEMBL2274357 0.89 KMT2A (0.44) MAPK14ALDH1A1TSHRMEN1KMT2A
SCHEMBL2274384 0.89 MAPT (0.44) MAPK14ALDH1A1TSHRMEN1KMT2A
SCHEMBL2272381 0.88 ACE2 (0.47) ALDH1A1TSHRMEN1KMT2ALMNA
SCHEMBL2271537 0.87 ALDH1A1 (0.46) MAPK14ALDH1A1MEN1KMT2AKCNK3
SCHEMBL2269057 0.83 ALDH1A1 (0.41) ALDH1A1TSHRMEN1KMT2ALMNA
SCHEMBL2273092 0.83 ALDH1A1 (0.46) ALDH1A1TSHRMEN1KMT2ALMNA
SCHEMBL2272438 0.82 TP53 (0.40) MAPK14ALDH1A1MEN1KMT2ALMNA
SCHEMBL2268881 0.82 PTPRC (0.47) ALDH1A1MEN1KMT2ALMNANPC1
SCHEMBL2274863 0.79 ALDH1A1 (0.55) ALDH1A1MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530465-B2 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2013-09-10 US claimed
US-20130059862-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof HUANG HSU-SHAN (TW) 2013-03-07 US claimed
US-8530465-B2 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2013-09-10 US disclosed
US-20130059862-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof HUANG HSU-SHAN (TW) 2013-03-07 US disclosed
US-8304415-B2 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2012-11-06 US disclosed
US-20110207739-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2011-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110207739-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof ANXA1, ANXA5, ANXA2 MAPK14 1134/4885ALDH1A1 1020/4885TSHR 3925/4885
US-20130059862-A1 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof ANXA5, ANXA1, HCCS MAPK14 2353/4885ALDH1A1 337/4885TSHR 4495/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.